Autoimmune diseases and cell therapies derived from umbilical cord stem cells (MSCs)
Background:
Lupus is a serious chronic autoimmune disease in which the immune system mistakenly attacks the body’s healthy tissues.
It manifests as episodes of flare-ups and remission, causing inflammation and damage in various parts of the body.
This condition can affect many organs, including the skin, joints, kidneys, blood and even the heart.
An innovative umbilical cord-derived cell therapy for severe lupus
Teams at the MATHEC centre at Saint-Louis Hospital (AP-HP), in collaboration with Paris Cité University, have conducted a study demonstrating the good tolerability of an umbilical cord-derived cell therapy in patients with severe lupus.
Preliminary results suggest a lasting clinical benefit in some patients.
Study published in The Lancet Rheumatology





